Carbon-based Nanomaterials and Curcumin: A Review of Biosensing Applications

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2021 Jul 31

PMID 34331684

Citations 3

Authors

Mohammad Mohajeri

Behzad Behnam

Aida Tasbandi

Tannaz Jamialahmadi

Amirhossein Sahebkar

Affiliations

Soon will be listed here.

Abstract

Curcumin, the main active constituent of turmeric (Curcuma longa L.), is a naturally occurring phenolic compound with a wide variety of pharmacological activities. Although it has multiple pharmaceutical properties, its bioavailability and industrial usage are hindered due to rapid hydrolysis and low water solubility. Due to the growing market of curcumin, exact determination of curcumin in trade and human biological samples is important for monitoring therapeutic actions. Different nanomaterials have been suggested for sensing curcumin; and in this case, carbon-based nanomaterials (CNMs) are one of the most outstanding developments in nanomedicine, biosensing, and regenerative medicine. There are a considerable number of reports which have shown interesting potential of CNMs-based biosensors in the sensitive and selective detection of curcumin. Therefore, this review aims to increase understanding the interaction of curcumin with CNMs in the context of biosensing.

Citing Articles

Fabrication of Curcumin-Based Electrochemical Nanosensors for the Detection of Environmental Pollutants: 1,4-Dioxane and Hydrazine.

Rasal R, Badsha I, Shellaiah M, Subramanian K, Gayathri A, Hirad A Biosensors (Basel). 2024; 14(6).

PMID: 38920595 PMC: 11202126. DOI: 10.3390/bios14060291.

Electrochemical Sensing of Curcumin: A Review.

Chiorcea-Paquim A Antioxidants (Basel). 2023; 12(12).

PMID: 38136149 PMC: 10740878. DOI: 10.3390/antiox12122029.

Curcumin Electrochemistry-Antioxidant Activity Assessment, Voltammetric Behavior and Quantitative Determination, Applications as Electrode Modifier.

David I, Iorgulescu E, Popa D, Buleandra M, Cheregi M, Noor H Antioxidants (Basel). 2023; 12(11).

PMID: 38001760 PMC: 10669510. DOI: 10.3390/antiox12111908.

References

Priyadarsini K . The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014; 19(12):20091-112. PMC: 6270789. DOI: 10.3390/molecules191220091. View

Lestari M, Indrayanto G . Curcumin. Profiles Drug Subst Excip Relat Methodol. 2014; 39:113-204. DOI: 10.1016/B978-0-12-800173-8.00003-9. View

Mahady G, Pendland S, Yun G, Lu Z . Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 2003; 22(6C):4179-81. View

Reddy R, Vatsala P, Keshamouni V, Padmanaban G, Rangarajan P . Curcumin for malaria therapy. Biochem Biophys Res Commun. 2004; 326(2):472-4. DOI: 10.1016/j.bbrc.2004.11.051. View

Vera-Ramirez L, Perez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles J . Curcumin and liver disease. Biofactors. 2013; 39(1):88-100. DOI: 10.1002/biof.1057. View

Wright L, Frye J, Gorti B, Timmermann B, Funk J . Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer. Curr Pharm Des. 2013; 19(34):6218-25. PMC: 3883055. DOI: 10.2174/1381612811319340013. View

Aggarwal B, Kumar A, Bharti A . Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003; 23(1A):363-98. View

Gupta S, Patchva S, Aggarwal B . Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2012; 15(1):195-218. PMC: 3535097. DOI: 10.1208/s12248-012-9432-8. View

Abdollahi E, Momtazi A, Johnston T, Sahebkar A . Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?. J Cell Physiol. 2017; 233(2):830-848. DOI: 10.1002/jcp.25778. View

10.

Iranshahi M, Sahebkar A, Takasaki M, Konoshima T, Tokuda H . Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. Eur J Cancer Prev. 2009; 18(5):412-5. DOI: 10.1097/CEJ.0b013e32832c389e. View

11.

Aggarwal B, Harikumar K . Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2008; 41(1):40-59. PMC: 2637808. DOI: 10.1016/j.biocel.2008.06.010. View

12.

Saberi Karimian M, Pirro M, Majeed M, Sahebkar A . Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev. 2016; 33:55-63. DOI: 10.1016/j.cytogfr.2016.10.001. View

13.

Mollazadeh H, Cicero A, Blesso C, Pirro M, Majeed M, Sahebkar A . Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr. 2017; 59(1):89-101. DOI: 10.1080/10408398.2017.1358139. View

14.

Panahi Y, Hosseini M, Khalili N, Naimi E, Simental-Mendia L, Majeed M . Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. Biomed Pharmacother. 2016; 82:578-82. DOI: 10.1016/j.biopha.2016.05.037. View

15.

Ireson C, Orr S, Jones D, Verschoyle R, Lim C, Luo J . Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001; 61(3):1058-64. View

16.

Sharma R, Euden S, Platton S, Cooke D, Shafayat A, Hewitt H . Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004; 10(20):6847-54. DOI: 10.1158/1078-0432.CCR-04-0744. View

17.

Harrison B, Atala A . Carbon nanotube applications for tissue engineering. Biomaterials. 2006; 28(2):344-53. DOI: 10.1016/j.biomaterials.2006.07.044. View

18.

Wang Z, Dai Z . Carbon nanomaterial-based electrochemical biosensors: an overview. Nanoscale. 2015; 7(15):6420-31. DOI: 10.1039/c5nr00585j. View

19.

Rezaee M, Behnam B, Banach M, Sahebkar A . The Yin and Yang of carbon nanomaterials in atherosclerosis. Biotechnol Adv. 2018; 36(8):2232-2247. DOI: 10.1016/j.biotechadv.2018.10.010. View

20.

Mohajeri M, Behnam B, Barreto G, Sahebkar A . Carbon nanomaterials and amyloid-beta interactions: potentials for the detection and treatment of Alzheimer's disease?. Pharmacol Res. 2019; 143:186-203. DOI: 10.1016/j.phrs.2019.03.023. View